[115+ Pages Research Study] According to Polaris Market Research report, the global cloning and mutagenesis market size & share expected to generate revenue of USD 9.29 billion by 2030 and estimated to be valued at USD 2.00 billion in 2021, at a compound annual growth rate (CAGR) of 18.7% from 2022 to 2030. The top market company profiles included in report with their sales, revenues and strategies are Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation and Others.
New York, NY, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled 'Cloning and Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030' in its research database.
'According to the latest research study, the global Cloning and Mutagenesis Market size & share are expected to generate revenue of USD 9.29 Billion By 2030 and are estimated to be valued at USD 2.00 billion in 2021, at a compound annual growth rate (CAGR) of 18.7% from 2022 to 2030'
What are Cloning And Mutagenesis? What is the Expected Size & Share of Cloning And Mutagenesis Market?
Cloning is the procedure of engineering the same organism, tissue, biological entity, or cell, either naturally or artificially. A biotechnology method is used to perform the artificial clone technology. Mutagenesis is the process by which the DNA of an organism is permanently changed, resulting in the production of gene mutation. Mutagenesis is performed experimentally in laboratory procedures where mutations in the DNA are formed for the production of mutation of the genes.
Cloning and mutagenesis is the technique used to study the structure and functionality of proteins, developed to confirm the effect of mutations both in vitro and in vivo. The growing adoption of cloning and mutagenesis technologies, such as PCR, due to the increasing demand for personalized medicine, is expected to drive the cloning and mutagenesis market size. The rising prevalence of genetic abnormalities and chronic diseases is further anticipated to boost the growth of the market.
Request Sample Copy of Research Report URL URL
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Our Sample Report May Includes:
2030 Updated Report Introduction, Overview, and In-depth industry analysis.
115+ Pages Research Report (Inclusion of Updated Research).
Provide Chapter-wise guidance on Request.
2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
Includes Updated List of tables & figures.
Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.
Some of the Top Market Players:
Agilent Technologies Inc.
Thermo Fisher Scientific Inc.
New England Biolabs
Takara Bio Inc.
Bio-Rad Laboratories Inc.
Jena Bioscience GmbH
TransGen Biotech Co. Ltd
For Additional Information on Key Players, Download a PDF Brochure: URL
Our Free Sample Report Includes
Report introduction, overview, and in-depth industry analysis
Breakdown data by regions, type, players, and applications
Competitive landscape and leading competitor market shares
110+ pages research report
Offers chapter-wise instruction on request
Includes market presence across different geographies with share, size, and trends
Updated list of tables and figures
The report covers leading players with their business strategies
Factors and fact research methodology
Growth Driving Factors
Rising popularity of reproductive cloning is likely to push the market growth
An increasing number of innovations and novel product launches in the cloning and mutagenesis market are expected to propel market growth. The growing popularity of reproductive cloning is predicted to contribute to the cloning and mutagenesis industry growth during the forecast period. Other factors, such as the rising use of personalized drugs and a surge in cases of genetic disorders and diseases like cancer and HIV, are likely to flourish the market expansion. Growing investments in R&D by key manufacturers in genetic diseases fuel the market demand.
Moreover, the rising focus on protein engineering for therapeutic development is escalating the growth prospects for the market. Technological developments in cloning services, along with increased synergistic industry activities, augment the cloning and mutagenesis market sales. A surge in strategic collaborations among private as well as government organizations is an additional factor projected to accelerate the industry's future growth.
Directly Purchase a copy of the report with TOC URL URL
Rising applications of cloning kits to fuel the market growth: Based on product, the market has been bifurcated into cloning kits and mutagenesis kits. The cloning kits category led the market in 2021 because they are utilized in sectors like biopharmaceuticals, gene therapy, and gene analysis. Thus, the rising use of these kits in the biotechnology industry is expected to boost segment growth in the cloning and mutagenesis market over the foreseen period.
A number of benefits are offered by TOPO PCR cloning technology to boost industry growth: Based on technology, the market is segmented into TOPO PCR Cloning and site-directed mutagenesis. The TOPO PCR cloning segment accounted for the highest revenue share in the cloning and mutagenesis market in 2021 because it offers various benefits compared to conventional TA cloning, such as no ligation and restriction on cloning, no need for post-PCR steps, and greater efficiency.
Rising focus of pharma companies on drug discovery to fuel the market expansion: Based on end-use, the market is categorized into biopharmaceuticals and pharmaceutical companies and CROs and CMOS. Pharmaceutical and biopharmaceutical companies witnessed the largest revenue share in 2021. This growth can be attributed to the rise in the prevalence of diseases and the growing focus of pharmaceutical and biopharmaceutical businesses on discovering and developing drugs.
Inquire more about this report before purchase URL URL
(Inquire about a report quote OR available discount offers to the sales team before purchase.)
Cloning And Mutagenesis Market Report Scope
Revenue forecast in 2030
USD 9.29 Billion
Market size value in 2022
USD 2.36 Billion
Expected CAGR Growth
18.7% from 2022 - 2030
2022 - 2030
Top Market Players
Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co., Ltd.
By product, By Technology, By End-use, By Region
Customized purchase options are available to meet any research needs. Explore customized purchase options
The demand in North America is expected to witness significant growth
In terms of geography, cloning and mutagenesis market demand in North America dominated the market in 2021 owing to the growing demand for biotechnology methods. Increased adoption of platforms grounded on genomic and proteomic data, which has led to increasing the use of cloning and mutagenesis methods, is majorly driving the market growth in North America.
Moreover, the Asia Pacific is expected to grow at the highest rate because of the rising requirement for novel treatments in the region. Other factor supporting regional growth of the cloning and mutagenesis market includes growing investment by the government in R&D, a rapidly growing economy, and rising infrastructure development.
Browse the Detail Report 'Cloning And Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030' with in-depth TOC: URL
For Additional Information OR Media Enquiry, Please Mail At: EMAIL
The U.S. business Telesis Bio, Inc. stated in May 2021 that its BioXp technology now supports long fragment cloning. With the aid of this endeavor, researchers can create multivariant, error-corrected vectors and clone them into bespoke vectors hand-free overnight.
Frequently Asked Questions
Who are the crucial companies operating the market?
What are the major industry norms influencing the development of the industry?
Which is the most propelling country in the industry?
Which application or product type will obtain progressive development possibilities during the forecast period?
What is the expected growth rate of the market during the foreseen period?
Polaris Market Research has segmented the cloning and mutagenesis market report based on product, technology, end-user, and region:
By Product Outlook
By Technology Outlook
TOPO PCR Cloning
By End-Use Outlook
Biopharmaceuticals and pharmaceutical companies
CROs and CMOs
By Region Outlook
North America (U.S., Canada)
Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Browse More Related Reports:
Healthcare Bioconvergence Market: URL
Dendritic Cell Cancer Vaccine Market: URL
Meningitis Diagnostic Testing Market: URL
Medical Spa Market: URL
DNA Synthesis Market: URL
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
Likhil G30 Wall Street8th Floor,New York City, NY 10005,United StatesPhone: +1-929 297-9727Email: __EMAIL__eb: URL